Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconVRTXVertex Pharmaceuticals$116.14bn28.79n/a
us flag iconREGNRegeneron Pharmaceuticals$81.10bn17.56n/a
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconIQVIqvia Holdings$36.63bn25.16n/a
us flag iconBNTXBioNTech SE$27.12bnn/an/a
us flag iconICLRIcon$17.69bn21.94n/a
us flag iconUTHRUnited Therapeutics$16.65bn15.62n/a
us flag iconMRNAModerna$15.82bnn/an/a
us flag iconSMMTSummit Therapeutics$14.01bnn/an/a
us flag iconINSMInsmed$13.09bnn/an/a
us flag iconNBIXNeurocrine Biosciences$12.72bn33.02n/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconTECHBIO-TECHNE$11.33bn55.690.45%
us flag iconPCVXVaxcyte$11.04bnn/an/a
us flag iconSRPTSarepta Therapeutics$10.91bn92.74n/a
us flag iconMEDPMedpace Holdings$10.47bn29.58n/a
us flag iconEXELExelixis$10.17bn19.92n/a
us flag iconCRLCharles River Laboratories International$10.01bn21.06n/a
us flag iconEXASExact Sciences$9.79bnn/an/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a